Clozapine reduces all-cause mortality

American Journal of Psychiatry

Volumn 174, Issue 10, 2017, Pages 920-921

  Kane, John M ^a  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

ALL CAUSE MORTALITY; AUTOMUTILATION; DRUG EFFICACY; EDITORIAL; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; RELAPSE; RISK REDUCTION; SUICIDE; TREATMENT RESPONSE; TREATMENT-RESISTANT SCHIZOPHRENIA; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; RISPERIDONE; SCHIZOPHRENIA;

EID: 85031321363     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2017.17070770     Document Type: Editorial

References (9)

1. Kane J, Honigfeld G, Singer J, et al: Clozapine for the treatmentresistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796
2. Meltzer HY, Alphs L, Green AI, et al: Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003; 60:82-91
3. Howes OD, McCutcheon R, Agid O, et al: Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry 2017; 174:216-229
4. Kane JM, Correll CU: The role of clozapine in treatment-resistant schizophrenia. JAMA Psychiatry 2016; 73:187-188
5. Samara MT, Dold M, Gianatsi M, et al: Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis. JAMA Psychiatry 2016; 73:199-210
6. Stroup TS, Gerhard T, Crystal S, et al: Comparative effectiveness of clozapine and standard antipsychotic treatment in adults with schizophrenia. Am J Psychiatry 2016; 173:166-173
7. Tiihonen J, Mittendorfer-Rutz E, Majak M, et al: Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia. JAMA Psychiatry 2017; 74:686-693
8. Nielsen J, Correll CU, Manu P, et al: Termination of clozapine treatment due to medical reasons: when is it warranted andhowcan it be avoided? J Clin Psychiatry 2013; 74:603-613
9. Wimberley T, MacCabe JH, Laursen TM, et al: Mortality and selfharm in association with clozapine in treatment-resistant schizophrenia. Am J Psychiatry 2017; 174:990-998